ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's Labs Q2 Results: Profit rises 33% YoY to Rs 1,480 crore, revenue up 9%
The company reported an EBITDA of Rs 2,181 crore in the September quarter, higher by 13% YoY. EBITDA margins in the same period came in at 31.7%.Segment-wise, revenue from the global generics business jumped 9% year-on-year to Rs 6,110 crore, primarily dri
Announcement as on 27 October 2023

Dr Reddy#39;s Q2 results: Net profit jumps 33% YoY to Rs 1,480 cr, tops estimate
Dr Reddy#39;s recorded its highest-ever net profit and topline in the July-September quarter.
Announcement as on 27 October 2023

Dr Reddy's Q2 results: Net profit after tax rises 33% to Rs 1,482 crore
Consolidated quarterly revenue rose 9% to 69.03 billion rupees led by a 9% growth in the key global generics segment
Announcement as on 27 October 2023

Stocks in news: RIL, Maruti, Vodafone Idea, Cipla, Dr Reddy's
Laxmi Organic reported net profit of Rs 10.7 crore for the quarter ended September. Revenue from operations stood at Rs 652 crore.
Announcement as on 27 October 2023

Dr Reddy's gears up for weight loss drug study
Dr Reddy's Laboratories has received approval from India's drug regulatory authority to conduct a bioequivalence study for the weight loss drug Semaglutide. The company had sought a waiver for the study and a Phase III clinical trial, but the SEC recommend
Announcement as on 18 October 2023

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 13.09
  • 12Day Average: 13.41
  • 20Day Average: 13.71
  • 50Day Average: 13.83
  • 100Day Average: 14.05
  • 150Day Average: 14.22
  • 200Day Average: 14.18

RDY Indicators & signals

Indicator MACD (12,26,9)

13.35, 13.62, -0.17
Indicator MACD is in negative zone

Indicator ADX (14)

17.65, 30.43, 43.48
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 33
Indicator RSI is indicating selling pressure and stock might fall.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
20 Tue Jan 2026 12.94 12.81 to 12.98 0.15% 1.82 times
16 Fri Jan 2026 12.92 12.91 to 13.06 -1.3% 1.09 times
15 Thu Jan 2026 13.09 13.08 to 13.24 -1.58% 1.02 times
14 Wed Jan 2026 13.30 13.17 to 13.30 0.61% 0.81 times
13 Tue Jan 2026 13.22 13.15 to 13.24 -1.93% 1.28 times
12 Mon Jan 2026 13.48 13.46 to 13.58 0.6% 0.79 times
09 Fri Jan 2026 13.40 13.38 to 13.52 0.37% 0.98 times
08 Thu Jan 2026 13.35 13.35 to 13.60 -2.41% 1.47 times
07 Wed Jan 2026 13.68 13.64 to 13.94 -1.3% 0.83 times
06 Tue Jan 2026 13.86 13.83 to 14.12 0.29% 0.95 times
05 Mon Jan 2026 13.82 13.74 to 13.88 -0.29% 0.79 times
02 Fri Jan 2026 13.86 13.66 to 13.92 -1.35% 0.84 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top